Andrew L Pecora Insider Trading $NBS CALADRIUS BIOSCIENCES, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Andrew L Pecora.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andrew L Pecora. Andrew L Pecora is Chief Medical Officer in Caladrius Biosciences, Inc. ($NBS) and Director in Caladrius Biosciences, Inc. ($NBS) and See Remarks in Caladrius Biosciences, Inc. ($NBS) and Director in TETRALOGIC PHARMACEUTICALS CORP ($TLOG).
Andrew L Pecora in CALADRIUS BIOSCIENCES, INC.
Trading Symbol: NBSIndustry: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
Position of Andrew L Pecora: Director, Chief Medical Officer, See Remarks
Holdings: 393,784 shares
Latest Transaction: Jun 23 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Andrew L Pecora in CALADRIUS BIOSCIENCES, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 23 2016 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Director | Option Exercise | A | 0.52 | 12,500 | 6,450 | 12,500 | |
Jun 23 2016 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Director | Grant | A | 0.00 | 7,500 | 0 | 393,784 | 386.3 K to 393.8 K (+1.94 %) |
Jan 27 2016 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Director | Option Exercise | A | 0.63 | 15,000 | 9,450 | 15,000 | |
Jan 27 2016 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Director | Grant | A | 0.00 | 9,000 | 0 | 386,284 | 377.3 K to 386.3 K (+2.39 %) |
Aug 27 2015 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Director | Grant | A | 1.27 | 3,108 | 3,947 | 377,284 | 374.2 K to 377.3 K (+0.83 %) |
Aug 14 2015 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Director | Grant | A | 1.40 | 2,831 | 3,963 | 374,176 | 371.3 K to 374.2 K (+0.76 %) |
Jul 30 2015 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Director | Grant | A | 1.74 | 2,277 | 3,962 | 371,345 | 369.1 K to 371.3 K (+0.62 %) |
Jul 17 2015 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Director | Grant | A | 1.90 | 2,086 | 3,963 | 369,068 | 367 K to 369.1 K (+0.57 %) |
Jul 02 2015 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Director | Grant | A | 1.89 | 2,097 | 3,963 | 366,982 | 364.9 K to 367 K (+0.57 %) |
Jul 02 2015 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Director | Grant | A | 1.87 | 227 | 424 | 364,885 | 364.7 K to 364.9 K (+0.06 %) |
Jul 02 2015 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Director | Grant | A | 1.59 | 6,702 | 10,653 | 364,658 | 358 K to 364.7 K (+1.87 %) |
Jun 18 2015 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Director | Grant | A | 1.95 | 1,597 | 3,114 | 357,956 | 356.4 K to 358 K (+0.45 %) |
Jun 04 2015 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Director | Grant | A | 2.34 | 1,330 | 3,112 | 356,359 | 355 K to 356.4 K (+0.37 %) |
Jun 04 2015 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Director | Grant | A | 0.00 | 10,000 | 0 | 355,029 | 345 K to 355 K (+2.90 %) |
May 21 2015 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Director | Grant | A | 2.30 | 1,354 | 3,114 | 345,029 | 343.7 K to 345 K (+0.39 %) |
May 21 2015 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Director | Grant | A | 0.00 | 925 | 0 | 343,675 | 342.8 K to 343.7 K (+0.27 %) |
May 07 2015 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Director | Grant | A | 2.38 | 1,308 | 3,113 | 342,750 | 341.4 K to 342.8 K (+0.38 %) |
May 07 2015 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Director | Payment of Exercise | F | 2.87 | 3,917 | 11,242 | 341,442 | 345.4 K to 341.4 K (-1.13 %) |
Apr 23 2015 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Director | Grant | A | 2.88 | 1,081 | 3,113 | 345,359 | 344.3 K to 345.4 K (+0.31 %) |
Apr 13 2015 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Director | Grant | A | 3.10 | 899 | 2,787 | 344,278 | 343.4 K to 344.3 K (+0.26 %) |
Mar 27 2015 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Director | Grant | A | 3.08 | 848 | 2,612 | 343,379 | 342.5 K to 343.4 K (+0.25 %) |
Mar 12 2015 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Director | Grant | A | 3.80 | 688 | 2,614 | 342,531 | 341.8 K to 342.5 K (+0.20 %) |
Feb 26 2015 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Director | Grant | A | 3.89 | 7 | 27 | 341,843 | 341.8 K to 341.8 K (0.00 %) |
Apr 25 2013 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Chief Medical Offic ... | Grant | A | 0.63 | 5,612 | 3,536 | 2,119,689 | 2.1 M to 2.1 M (+0.27 %) |
Dec 20 2012 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Chief Medical Offic ... | Grant | A | 0.61 | 7,226 | 4,408 | 2,072,278 | 2.1 M to 2.1 M (+0.35 %) |
Dec 14 2012 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Chief Medical Offic ... | Grant | A | 0.64 | 6,887 | 4,408 | 2,065,052 | 2.1 M to 2.1 M (+0.33 %) |
Nov 26 2012 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Chief Medical Offic ... | Grant | A | 0.71 | 4,786 | 3,390 | 2,058,175 | 2.1 M to 2.1 M (+0.23 %) |
Nov 26 2012 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Chief Medical Offic ... | Grant | A | 0.67 | 6,934 | 4,646 | 2,053,389 | 2 M to 2.1 M (+0.34 %) |
Nov 13 2012 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Chief Medical Offic ... | Grant | A | 0.63 | 6,362 | 4,008 | 2,046,445 | 2 M to 2 M (+0.31 %) |
Oct 26 2012 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Chief Medical Offic ... | Grant | A | 0.71 | 6,771 | 4,807 | 2,040,083 | 2 M to 2 M (+0.33 %) |
Oct 01 2012 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Chief Medical Offic ... | Grant | A | 0.69 | 11,794 | 8,138 | 2,033,312 | 2 M to 2 M (+0.58 %) |
Apr 30 2012 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Chief Medical Offic ... | Option Exercise | A | 0.36 | 140,000 | 50,400 | 140,000 | |
Apr 30 2012 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Chief Medical Offic ... | Grant | A | 0.36 | 7,536 | 2,713 | 2,021,518 | 2 M to 2 M (+0.37 %) |
Apr 16 2012 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Chief Medical Offic ... | Grant | A | 0.32 | 8,478 | 2,713 | 2,013,982 | 2 M to 2 M (+0.42 %) |
Jan 06 2012 | NBS | Caladrius Bioscien ... | Pecora Andrew L | See Remarks | Option Exercise | A | 0.52 | 175,000 | 91,000 | 175,000 | |
Dec 15 2011 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Chief Medical Offic ... | Buy | P | 0.60 | 10,000 | 6,000 | 2,005,504 | 2 M to 2 M (+0.50 %) |
Dec 15 2011 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Chief Medical Offic ... | Buy | P | 0.59 | 40,000 | 23,600 | 1,995,504 | 2 M to 2 M (+2.05 %) |
Oct 27 2011 | NBS | Caladrius Bioscien ... | Pecora Andrew L | See Remarks | Option Exercise | J | 1.47 | 10,575 | 15,503 | 10,575 | |
Oct 27 2011 | NBS | Caladrius Bioscien ... | Pecora Andrew L | See Remarks | Buy | J | 1.47 | 32,852 | 48,161 | 1,955,504 | 1.9 M to 2 M (+1.71 %) |
Aug 19 2011 | NBS | Caladrius Bioscien ... | Pecora Andrew L | See Remarks | Option Exercise | A | 0.71 | 500,000 | 355,000 | 500,000 | |
Mar 04 2011 | NBS | Caladrius Bioscien ... | Pecora Andrew L | See Remarks | Buy | P | 1.28 | 78,125 | 100,000 | 1,922,652 | 1.8 M to 1.9 M (+4.24 %) |
Jan 21 2011 | NBS | Caladrius Bioscien ... | Pecora Andrew L | See Remarks | Option Exercise | A | 1.50 | 400,000 | 600,000 | 400,000 |
Page: 1